Overview

Amantadine Therapy for Cognitive Impairment in Long COVID

Status:
Recruiting
Trial end date:
2025-05-15
Target enrollment:
Participant gender:
Summary
This study will look at the effects of amantadine on cognitive function in persons with Long COVID. It will also collect specimens to study possible causes of cognitive symptoms in Long COVID, and whether any lab tests can predict who will respond better to amantadine.
Phase:
Phase 1
Details
Lead Sponsor:
Ohio State University
Treatments:
Amantadine